A review of Cabenuva®, an antiret...
A review of Cabenuva®, an antiretroviral agent for HIV.

The Canadian Breakpoint by Dr. Rupeena Purewal

Episode notes

Dr. Rupeena Purewal invites special guest Saskatoon pharmacist Carley Pozniak to review Cabenuva®, an antiretroviral agent for HIV. Cabenuva® (Cabotegravir Extended Release Injectable Suspension) has been approved in 2020 for medical use in Canada.

Keywords
cabenuva